Agenus Inc (NAS:AGEN) Stock News, Headlines & Updates
Agenus Inc Stock News from GuruFocus
- 1
Jun 28, 2024
Significant Tumor Reductions in Neoadjuvant MSS Colon Cancer Patients Treated with Botensilimab/Balstilimab Presented at ESMO GI Conference
Business Wire • 11:00am
Jun 27, 2024
Cancer Therapy Evaluation Program Announces Availability of Botensilimab for Clinical Studies
Business Wire • 7:00am
Jun 17, 2024
Agenus Announces Appointment of Dr. Jennifer Buell to Its Board of Directors
Business Wire • 7:00am
Jun 13, 2024
Nature Medicine Reports Agenus' Novel Immunotherapy Demonstrates Clinical Activity Against a Deadly Form of Colorectal Cancer on the Rise in Americans Under 50
Business Wire • 5:00am
Jun 04, 2024
Agenus Announces Virtual Annual Shareholders Meeting
Business Wire • 7:00am
May 24, 2024
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire • 5:00pm
May 23, 2024
Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
Business Wire • 5:00pm
Agenus to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
Business Wire • 7:00am
May 16, 2024
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
Business Wire • 7:00am
May 08, 2024
Agenus Inc (AGEN) Q1 2024 Earnings Call Transcript Highlights: Strategic Developments and Financial Updates
GuruFocus Research • 1:09am
Q1 2024 Agenus Inc Earnings Call Transcript
GuruFocus Research • 11:12pm
May 07, 2024
Agenus Reports First Quarter 2024 Results
Business Wire • 7:00am
Agenus Inc (AGEN) Q1 2024 Earnings: Misses Revenue and EPS Estimates Amid Strategic Developments
GuruFocus Research • 6:56am
May 01, 2024
Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
Business Wire • 7:00am
Apr 24, 2024
Botensilimab/Balstilimab Data in MSS CRC Selected for the American Society of Clinical Oncology 2024 Annual Meeting
Business Wire • 10:00am
Apr 23, 2024
Agenus to Provide First Quarter 2024 Financial Report and Corporate Update
Business Wire • 7:00am
Apr 12, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news